ask="7.45"
ask_size="100"
average_daily_volume="1404800"
bid="7.35"
bid_size="100"
book_value="0.05"
change="+0.56"
change_from_200_day_moving_average="2.14"
change_from_50_day_moving_average="1.38"
change_from_52_week_high="-0.14"
change_From_52_week_low="5.06"
change_in_percent="+8.16%"
close="7.42"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.75"
ebitda="-48.19M"
eps_estimate_current_year="-0.68"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.66"
ex_dividend_date="N/A"
float_shares="46578000"
high="7.51"
high_52_weeks="7.56"
last_trade_date="3/2/2017"
last_trade_price="7.42"
last_trade_size="52416"
last_trade_time="4:00pm"
low="6.58"
low_52_weeks="2.36"
market_capitalization="547.28M"
moving_average_200_day="5.28"
moving_average_50_day="6.04"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.78"
open="6.87"
pe_ratio="N/A"
peg_ratio="-0.51"
percent_change_from_200_day_moving_average="+40.49%"
percent_change_from_50_day_moving_average="+22.81%"
percent_change_from_52_week_high="-1.85%"
percent_change_from_52_week_low="+214.41%"
previous_close="6.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="127.04"
price_per_sales="19.20"
revenue="26.35M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="4590904"
weeks_range_52="2.36 - 7.56"
